TAKEDA PHARM.SPON.ADR/1/2 - stock earnings
TKDA.F Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 678.1 million EUR | 7.1 billion EUR |
| 2023Q3 | -303.7 million EUR | 6.6 billion EUR |
| 2023Q2 | 568.8 million EUR | 6.7 billion EUR |
| 2023Q1 | 215.0 million EUR | 6.6 billion EUR |
| 2022Q4 | 847.6 million EUR | 7.8 billion EUR |
| 2022Q3 | 435.7 million EUR | 7.1 billion EUR |
| 2022Q2 | 736.4 million EUR | 6.8 billion EUR |
| 2022Q1 | -83.3 million EUR | 6.4 billion EUR |
| 2021Q4 | 441.4 million EUR | 6.9 billion EUR |
| 2021Q3 | 356.5 million EUR | 6.6 billion EUR |
| 2021Q2 | 1.5 billion EUR | 7.2 billion EUR |
| 2021Q1 | 1.5 billion EUR | 5.9 billion EUR |
| 2020Q4 | 734.6 million EUR | 6.7 billion EUR |
| 2020Q3 | 32.6 million EUR | 6.4 billion EUR |
| 2020Q2 | 680.3 million EUR | 6.6 billion EUR |
| 2020Q1 | 14.5 million EUR | 6.5 billion EUR |
| 2019Q4 | -264.1 million EUR | 7.0 billion EUR |
| 2019Q3 | 457.9 million EUR | 6.9 billion EUR |
TKDA.F Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.2 billion EUR | 27.8 billion EUR |
| 2022 | 1.7 billion EUR | 26.2 billion EUR |
| 2021 | 2.9 billion EUR | 24.6 billion EUR |
| 2020 | 371.3 million EUR | 27.6 billion EUR |
| 2019 | 878.5 million EUR | 16.9 billion EUR |
| 2018 | 1.4 billion EUR | 13.5 billion EUR |
| 2017 | 962.3 million EUR | 14.5 billion EUR |
TKDA.F
Price: €12.10
Dividend Yield: 14.72%
Forward Dividend Yield: 0.02%
Payout Ratio: 0.69%
Dividend Per Share: 0.00 EUR
Earnings Per Share: 0.34 EUR
P/E Ratio: 33.68
Exchange: FRA
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 200
Market Capitalization: 39.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 5
DGR3: -19.36%